No Picture
Trading Ideas

Jury in Manafort trial: What if we can’t agree on 1 count?

The jury in the financial fraud trial of former Trump campaign chairman Paul Manafort asked the judge Tuesday what it should do if it cannot reach a consensus for a single count in the case. The jury in Alexandria, Virginia is weighing 18 counts against Manafort, who is accused of hiding millions of dollars in foreign income from Ukraine and of lying on loan applications to maintain a lavish lifestyle. Manafort’s attorneys called no witnesses in his defense, arguing that the prosecution failed to meet their burden of proof. …read more […]

No Picture
Trading Ideas

Apple Stock Is Ready for a Turn Lower

It’s smelling like roses these days, but technically speaking Apple (NASDAQ:AAPL) is ripe for turning less sweet with investors. From its earnings beat to chatter over low-cost Macs and a fresh Apple Watch on the horizon, Apple’s stock has surged 13% in August to reach all-time-highs and cement its place as the world’s first trillion-dollar public company. Bank of America’s recent upgrade only serves to bolster the case for investing in Apple’s growth. …read more […]

No Picture
Trading Ideas

Another Wall Street bank has dropped coverage of Tesla — and it could be a sign Elon Musk is making progress in taking the company private (TSLA)

Morgan Stanley has joined Goldman Sachs in restricting its research coverage of Tesla. Tesla CEO Elon Musk is attempting to take the electric-car maker private and has begun tapping banks for services. Follow Tesla’s stock price in real time here. …read more […]

No Picture
Trading Ideas

The Selling Binge in NFLX Stock Has Finally Ended

Netflix (NASDAQ: NFLX) has certainly had a tough time of it recently. After being one of the best performing internet stocks in the first half of the year, NFLX stock has crashed back to reality. Certainly some of the sell off was warranted given the disappointing subscriber growth and ongoing cash burn. …read more […]

No Picture
Trading Ideas

Medtronic beats profit estimate on cardiac, diabetes business, hits record high

Medtronic Plc posted a better-than-expected quarterly profit on Tuesday, helped by strong sales of its diabetes and heart devices, sending the medical device maker’s shares up as much as 4.9 percent to a record high. Dublin-based Medtronic’s performance was in line with other device makers such as Boston Scientific Corp and Baxter International Inc that have also reported stronger-than-expected quarterly results. The largest U.S. standalone device maker’s diabetes unit that makes insulin pumps and glucose monitoring systems posted a 27 percent rise in sales, largely due to strong adoption …read more […]